First Day Predictors of Requirement of Mechanical Ventilation in COPD Patients with Acute Exacerbation by Dhanus Sadasivan Nair,
FIRST DAY PREDICTORS OF REQUIREMENT OF 
MECHANICAL VENTILATION IN COPD 
PATIENTS WITH ACUTE EXACERBATION 
 
 
 
 
 
 
 
DISSERTATION SUBMITTED FOR 
 
M.D GENERAL MEDICINE 
 
BRANCH –I 
 
APRIL 2017 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THE TAMILNADU 
 
DR.M.G.R. MEDICAL UNIVERSITY 
 
CHENNAI 
 
CERTIFICATE FROM THE DEAN 
 
 
 
 
This  is  to  certify  that  this  dissertation  entitled  “FIRST DAY PREDICTORS 
OF REQUIREMENT OF MECHANICAL VENTILATION IN COPD 
PATIENTS WITH ACUTE EXACERBATION” is the bonafide work of 
Dr.DHANUS SADASIVAN NAIR  in partial fulfilment of the university 
regulations of the Tamil Nadu Dr. M.G.R. Medical University, Chennai, for M.D 
General Medicine Branch I examination to be held in April 2017. 
 
 
 
 
 
 
 
 
 
 
 
 
Dr. M.R. VAIRAMUTHU RAJU MD. 
 
THE DEAN 
 
Madurai Medical College and 
 
Government Rajaji Hospital, 
 
Madurai. 
 
 
 
CERTIFICATE FROM THE HOD/GUIDE 
 
 
 
 
This  is  to  certify  that  this  dissertation  entitled  “FIRST DAY PREDICTORS 
OF REQUIREMENT OF MECHANICAL VENTILATION IN COPD 
PATIENTS WITH ACUTE EXACERBATION” is the bonafide work of 
Dr.DHANUS SADASIVAN NAIR  in partial fulfilment of the university 
regulations of the Tamil Nadu Dr. M.G.R. Medical University, Chennai, for M.D 
General Medicine Branch I examination to be held in April 2017. 
 
 
 
 
 
 
 
 
 
 
 
 
Dr.V.T.PREM KUMAR,M.D., 
 
Professor and HOD, 
 
Department Of General Medicine, 
 
Government Rajaji Hospital, 
 
Madurai Medical College, 
 
Madurai. 
 
 
 
 
 
 
 
 
DECLARATION 
 
 
I  Dr.DHANUS SADASIVAN NAIR,  declare  that,  I  carried  out  this  work  on  
“FIRST DAY PREDICTORS OF REQUIREMENT OF MECHANICAL 
VENTILATION IN COPD PATIENTS WITH ACUTE EXACERBATION” 
at the Department of Medicine, Govt. Rajaji Hospital during the period AUGUST 
2015 to AUGUST 2016. I also declare that this bonafide work or a part of this 
work was not submitted by me or any others for any award, degree or diploma to 
any other University, Board either in India or abroad.This is submitted to The 
Tamilnadu Dr.M.G.R.Medical University, Chennai in partial fulfillment of the 
rules and regulations for the M.D degree examination in General Medicine. 
 
 
 
 
 
 
 
Place : Madurai 
 
Dr.DHANUS SADASIVAN NAIR 
 
 
Date: 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
At the outset, I wish to thank our Dean 
 
Dr. VAIRAMUTHU RAJU, for permitting me to use the facilities of Madurai 
Medical College and Government Rajaji Hospital to conduct this study. 
 
My beloved Head Of the Department of Medicine, 
Prof.Dr.V.T.Prem kumar.M.D., has always guided me, by example and valuable 
 
words of advice and has encouraged innovative thinking and original research 
work done by post graduates. 
 
I also   sincerely  thank   our   beloved   professors   Dr.R.Balajinathan.M.D., 
 
Dr.M.Natarajan.M.D., Dr.G.Bagialakshmi,M.D., Dr.J.Sangumani.M.D., 
Dr.C.Dharmaraj.M.D., and Dr.R.Prabhakaran.M.D for their par excellence 
clinical teaching and constant support. 
 
I am extremely grateful to the Head of the department of Thoracic 
medicine Prof. Prabakaran MD for his constant support, guidance, cooperation 
and encouragement to complete this study. 
 
 
 
 
 
 
 
I would also like to acknowledge the support of Head of the department of 
Biochemistry, Madurai medical college Dr. Meenakumari MD for their 
laboratory assistance to the study. 
 
I offer my heartfelt thanks to my Unit 
Assistant Professors Dr.S. Murugesan MD.,  Dr.K. Muralidharan MD., 
 
Dr.S. Peer Mohamed MD for their constant encouragement, timely help and 
critical suggestions throughout the study and also for making my stay in the unit 
both informative and pleasurable. 
 
My patients, who form the most integral part of the work, were always kind 
and cooperative. I pray to God give them courage and strength to endure their 
illness, hope all of them go into complete remission. 
 
I thank my friends and family who have stood by me during my times of 
need. Their help and support have always been invaluable to me. And last but not 
the least I would like thank the Lord Almighty for His grace and blessings without 
which nothing would have been possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS 
 
 
 
 
FEV1 - forced expiratory volume 
FVC - forced vital capacity 
COPD - chronic obstructive pulmonary disease 
PFT -pulmonary function test 
GOLD - global guidelines for obstructive pulmonary diseases 
SHT - systemic hypertension 
IU - international unit 
 
 
 
   
T2DM  - type 2 diabetic mellitus 
ECG - Electrocardiogram 
SD - Standard Deviation 
 
 
CVA - cerebrovascular accident 
 
CAD –  coronary artery disease 
 
 
CKD -  chronic kidney disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTENTS 
 
 
 
 
 
 
S. NO.  TITLE PAGE NO. 
    
1  INTRODUCTION 2 
    
2  AIMS AND OBJECTIVES 4 
    
3  REVIEW OF LITERATURE 5 
   
4 MATERIALS AND METHODS 37 
   
5 OBSERVATION AND RESULTS 47 
    
6  DISCUSSION 67 
    
7  LIMITATIONS 71 
    
8  SUMMARY 72 
    
9  CONCLUSION 75 
    
  ANNEXURES  
  BIBLIOGRAPHY  
  PROFORMA  
10   77 
  MASTER CHART  
  
 
ETHICAL CLEARANCE 
CERTIFICATE  
  TURNITIN CERTIFICATE  
    
 
 
FIRST DAY PREDICTORS OF REQUIREMENT OF 
MECHANICAL VENTILATION IN COPD 
PATIENTS WITH ACUTE EXACERBATION 
 
 
 
 
 
 
 
DISSERTATION SUBMITTED FOR 
 
M.D GENERAL MEDICINE 
 
BRANCH –I 
 
APRIL 2017 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THE TAMILNADU 
 
DR.M.G.R. MEDICAL UNIVERSITY 
 
CHENNAI 
 
 INTRODUCTION 
 
 
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading  
cause of mortality and the 12th leading cause of disability worldwide today. 
The worldwide prevalence of COPD is estimated at 9/1000 men and 7/1000 
women. COPD commonly affects elderly adults with a prevalence of 15%. 
Studies involving COPD patients with acute exacerbations discovered a 
combined mortality of 20.3% with prevalence of mechanical ventilation at 9-
67%. 
India being a developing country, there is severe limitation of health 
care facilities and scarcity of availability of intensive health care facilities. 
Reforms in economic and health care fields have resulted in an increase in the 
life expectancy of Indian adults which in turn has lead to an increasing 
incidence of age related morbidities like COPD. The number of COPD patients 
who are at risk of developing acute respiratory failure and who may benefit 
from mechanical ventilation vastly outnumbers the critical care facilities 
available to deal with this burden. Hence, methods to stratify the patients 
based on need for intubation and mechanical ventilation are imperative. 
In view of this current scenario, identification on the first day of 
admission, of those COPD patients with exacerbation who may require 
intubation and mechanical ventilation during the course of their hospital stay, 
will allow prompt arrangement and appropriate utilization of these scanty 
critical care facilities. 
APACHE II (Acute Physiology and Chronic Health Evaluation II) is a severity-of-
disease classification system , one of several ICU scoring systems. It is applied 
within 24 hours of admission of patient and calculated from 12 routine 
physiological measurements and 2 disease related variables. The APACHE II score 
ranges from 0 to 71 points, with the highest number of points pointing to a more 
severe form of disease. 
Premorbid functional status is a measure of morbidity that indicates the severity 
of dyspnea, the degree of independence in performing everyday activities, which 
indicates the severity of the underlying COPD and associated conditions. 
 
 
 
 
 
 
 
  
AIMS AND OBJECTIVES: 
 
 
 
 To identify the first day predictors of requirement of mechanical ventilation in 
COPD patients with acute exacerbation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
 
COPD has been defined as “ a disease state  characterised by airflow limitation that 
is not fully reversible.” COPD  includes emphysema, anatomically defined by the 
destruction and enlargement of  distal airspaces; chronic bronchitis, clinically 
defined by chronic cough and sputum; and small airways disease causing 
bronchiolar narrowing. 
 
RISK FACTORS-  
1) Cigarette smoking is definitively the most important identifiable causative factor 
of COPD. However, only 20% of smokers go on to develop clinically significant 
disease. Pack years of smoking is the most highly significant predictor of FEV1. 
 The above table depicts the effect of age on airflow obstruction in normal subjects 
and in susceptible cigarette smokers. Quitting the smoking habit will return the rate 
of decline to the normal trend. 
 Mean FEV1 after bronchodilator administration in ex-smokers who maintained 
abstinence compared with smokers who continued to smoke is depicted in the 
above chart.  
 The above table depicts the distribution of (FEV1) values in  general population, 
differentiated by packyears measuring duration of smoking.  
 Dose-response relationship between smoking intensity and FEV1 was 
identified, but marked differences  in PFT was seen among smokers with similar 
duration and smoking habits. 
 
 
  
2) Airway hyperresponsiveness, one of the characteristic features of bronchial 
asthma, is seen in many patients with COPD.  
Overlap between asthma and COPD was the basis for the formation of Dutch 
hypothesis which proposes that asthma, emphysema and chronic bronchitis are 
variations of the same disease, altered by genetics and environment to produce 
these phenotypes.  
The British hypothesis proposes that asthma is completely different from COPD- 
asthma being an allergic phenomenon and COPD the sequel of smoking related 
inflammation and damage. 
 
 
 
 
 
 A non proportional Venn diagram describing the relation between asthma, 
emphysema and chronic bronchitis/ the broken line rectangle includes all patients 
with airflow obstruction. Patients in subsets 1 and 2 have clinical or radiological 
features of chronic bronchitis or emphysema but do not have airflow obstruction 
and thus have a normal FEV1 and FEV1/FVC ratio. These patients are not 
classified as having COPD. Patients in subsets 6-8  have partially reversible 
airflow obstruction. Subsets 3-5 have no significant reversibility and patients in 
subset 8 have features of all three disorders. Those in subset 9 have completely 
reversible airflow obstruction and thus classified as asthma. Those in subset 10 
have airflow obstruction due to specific causes like cystic fibrosis, bronchiectasis. 
Patients with COPD are those within the thick shaded band. 
3) Ambient air pollution is a much less significant risk factor than cigarette 
smoking 
4) Passive smoking exposure has been linked to decreased lung function, but 
relation with COPD remains unproven 
 
PATHOGENESIS OF COPD 
 
 
Both chronic bronchitis and emphysema produce airway narrowing but evidence of 
obstruction need not be present. Airway obstruction is always seen by the time the 
patient becomes dyspnoeic. Airflow limitation, which is the major physiological 
change in COPD, can result from both small airway obstruction and emphysema. 
 
 PROTEASE- ANTIPROTEASE THEORY  -  
Cigarette smoke has a pro- oxidant effect, which makes neutrophils less 
deformable and causes neutrophil sequestration in the pulmonary capillaries. 
Activated neutrophils initially adhere to the endothelium and then  migrate to the 
airspaces. The pro-oxidants from cigarette smoke or released by activated airspace 
neutrophils inactivate antiproteases , mainly elastase. Elastase enters the lung 
interstitium and destroys elastin , causing destruction and enlargement of  distal 
airspaces.  
 
  
INFLAMMATION AND EXTRACELLULAR MATRIX HYPOTHESIS:- 
Macrophages and epithelial cells are activated on exposure to oxidants in cigarette 
smoke and produce chemokines that attract inflammatory cells, for example matrix 
metalloproteinases, IL-8 and TNF which lead to neutrophil recruitment.CD8+T 
cells are also recruited and release interferon inducible protein-10 (IP-10) which 
simulate macrophage production of macrophage elastase- matrix 
metalloproteinase-12. 
 
Matrix metalloproteinases and serine proteinases (especially neutrophil elastase) 
work synergistically by degrading the other‟s inhibitor and produce lung 
destruction. 
 
 
 
 
 
 
 
 
 
  
TYPES OF EMPHYSEMA- 
 
 
 Centriacinar- destruction of central acinus, commonly affect upper lobes, 
common in smokers 
 Panacinar- widespread destruction of acinus, commonly affect lower zones, 
common in antitrypsin deficiency 
 Paraseptal- affects the distal acinus, can cause spontaneous pneumothorax 
 
  
The above picture demonstrates the multiple individual pathologies ultimately 
leading to small airway disease with reduction of FEV1. 
 
CELL DEATH AND INEFFECTIVE REPAIR:- 
 
Structural cell death caused by oxidants in cigarette smoke occurs through a 
number of mechanisms, including rt801 inhibition of mammalian target of 
rapamycin (mTOR), leading to cell death and proteolysis. Involvement of mTOR 
and other senescence indicators has funded recent theories that emphysema is a 
type of premature accelerated ageing of lung. Macrophage uptake of apoptotic 
cells is inhibited by cigarette smoke, which limits repair 
  
 
 
 
 
 
 
PATHOPHYSIOLOGY OF COPD 
 
Persistent reduction in forced expiratory flow rates is the most typical finding in 
COPD. 
 
AIRFLOW OBSTRUCTION:- 
Also known as airflow limitation, it is evaluated by spirometry, by forced 
expiratory maneuvers after patient inhales to total lung capacity. Most important 
measurements are the volume of air exhaled in the first second of the forced 
expiratory maneuver (FEV1) and the total volume of air exhaled during the 
complete spirometric maneuver {Forced Vital Capacity (FVC)}. Airflow  
obstruction of COPD is identified by a persistently reduced FEV1/FVC ratio. 
Unlike bronchial asthma, the decreased FEV1 in COPD does not show 
improvements more than 15% in response to inhaled bronchodilators. 
The airflow in forced exhalation depends upon the balance between elastic recoil 
of the lungs which assists flow and the airway resistance inhibiting flow. In COPD, 
maximal expiratory flow decreases as the lung empties because the parenchyma 
gives progressively less recoil and the airflow resistance increases due to decrease 
in airway cross sectional area. 
 
 
HYPERINFLATION:- 
Pulmonary function tests also measure lung volumes. “Air trapping” {increased 
residual volume and increased ratio of residual volume to total lung capacity} and 
increasing hyperinflation {increased total lung capacity}  occurs in COPD. 
Hyperinflation is an initial compensatory mechanism which helps in maintaining 
maximal expiratory airflow, as the increased lung volume increases the elastic 
recoil and the airways enlarge decreasing the airway resistance. 
However, the flattening of diaphragm due to hyperinflation of lungs is adverse for 
the COPD patient:- 
1) As diaphragm and abdominal wall are now closely apposed, positive abdominal   
pressure in inspiration can not be as effectively delivered to chest, which decreases 
rib cage movement and impairs inspiration. 
2) The muscle fibres of the flattened diaphragm are shorter than normal and hence, 
less able to produce normal inspiratory pressures. 
3) Flat diaphragm has increased radius of curvature r, hence,  increased tension t  
must be produced to maintain transpulmonary pressure p for tidal breathing- 
{LAPLACE LAW p=2t/r} 
4) Inspiratory muscles must over work to overcome the resistance of the expanded 
thoracic cage. 
 
 The above diagram depicts the mechanisms by which flat diaphragm eventually 
contributes to COPD morbidity 
GAS EXCHANGE:- 
Partial pressure of oxygen in arterial blood PaO2 remains normal until FEV1 
decreases to less than 50% of predicted. Increased PaCO2 occurs only when FEV1 
decreases to less than 25% of predicted. 
 Pulmonary hypertension causing cor pulmonale and right ventricular failure 
occurs when FEV1 decreases to less than 25% of predicted with chronic 
hypoxemia ( PaO2 < 55mm Hg).  
 
Mechanism of development of Pulmonary Hypertension in COPD- 
 Degeneration of the vascular bed in lungs 
 Alterations in blood gas tension 
 Alterations in lung mechanics 
 Elevated cardiac output 
 Alterations in blood volume 
 Increased velocity of blood 
 Changes in lung endothelium 
 
Nonuniform ventilation and ventilation perfusion mismatch is characteristic of 
COPD, showing that the disease process is truly heterogenous. Ventilation 
perfusion mismatch is responsible for most of the reduction in PaO2 of COPD, 
which is why even modest elevations of inspired oxygen is so effective in 
correcting hypoxemia due to COPD, so much so that other problems should be 
looked for if hypoxemia is not corrected by modest levels of supplemental oxygen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIAGNOSIS: 
   
 
COPD must be thought of in patients with chronic complaints of 
cough, sputum production or dyspnea with history of smoking and exposure to risk 
factors.  
 
 
 
SEVERITY SCORES FOR RESPIRATORY DISEASES:- 
 
 
 
 The diagnosis  is made by spirometry. 
 
  
 
 
 
 
 
  
 
PULMONARY FUNCTION TESTING: 
 
 
A post bronchodilator FEV1/ FVC < 0.7 confirms airway obstruction 
that is not completely reversible. Increased lung volumes may point to emphysema. 
PEFR is reduced, DLCO is normal or slightly reduced in patients with chronic 
bronchitis and severe  reduction indicates associated  severe emphysema. 
 
 
 
 
 
 
 
 
According to GOLD guidelines, patients have been categorised into mild (stage 1), 
moderate (stage 2), severe (stage 3) and very severe (stage 4) based on percentage 
predicted FEV1 of more than or equal to 80, 50 to 80, 30 to 50, less than or equal 
to 30, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 COPD- GOLD criteria 
 
 
GOLD Stage 
 
SEVERITY 
 
SPIROMETRY 
 
I 
 
Mild 
 
FEV1/FVC<0.7 and FEV1 
>80% predicted 
 
II 
 
Moderate 
 
FEV1/FVC<0.7 and FEV1 
>50% but <80% predicted 
 
III 
 
Severe 
 
FEV1/FVC<0.7 and FEV1 
>30% but <50% predicted 
 
IV 
 
Very Severe 
 
FEV1/FVC<0.7 and FEV1 
<30% predicted 
 
 
 
 
 
 
 
 IMAGING : 
 
 
Chest X-ray may be normal or show emphysematous changes. It is 
very useful in ruling out other differential diagnoses and in detecting complications 
of COPD, including life threatening ones like pneumothorax. Patients with chronic 
bronchitis may have thick bronchial walls which appear as tubular or tram track 
shadows with  increased vascular markings. 
 
Chest X-ray in symptomatic emphysematous patients reveals dark 
hyperlucent lung fields with decreased vascular markings, characteristic bullae, 
flattened and pushed-down diaphragm and tube-like heart.  
 
HRCT can readily detect emphysema but is not used routinely for the 
purpose of diagnosis. Contrast-enhanced computed tomography (CECT) chest may 
show a  dilated pulmonary artery, indicating pulmonary hypertension. 
 
ACUTE EXACERBATION:- 
An exacerbation is defined as an episode of increased cough, dyspnea and altered 
volume and character of sputum, with or without other signs of disease.the 
frequency of exacerbations greatly affects quality of life of COPD patients, 
especially those with GOLD stage III or IV, who experience one to  four 
exacerbations in a year.  
Chances of exacerbation in future are increased by a previous history of 
exacerbation and an increased ratio of pulmonary artery diameter to aorta diameter 
on Chest CT. 
Bacterial infection accounts for more than half of exacerbations, with viral 
infections being involved in 30% and remaining 20 % cases having no obvious 
precipitating cause. 
 
Prevention of exacerbations is achieved to a great degree of success with inhaled 
steroids, anticholinergics and long acting beta agonists.  
Treatment is by inhaled beta agonists, along with anticholinergic agent, antibiotics, 
oral glucocorticoids and supplemental O2. 
 The above table shows the “ Chronic Obstructive Pulmonary Disease Escalator”- 
treatments need to be escalated as the lung function progressively decreases.  
 
 The above table depicts a summary of the physiopathology of the hypercapnic 
acute respiratory failure in COPD and the points where non invasive and 
mechanical ventilation acts in blocking these mechanisms. 
 
 
 
 
 
Non invasive Ventilation is indicated in- 
A. Moderate to severe dyspnea with evidence of increased work of breathing 
B. Acute respiratory acidosis wih pH <7.35 and PaCO2> 45 mmHg 
C. Respiratory rate >25 
 
 
 
The above table depicts the lung mechanics in Non Invasive Ventilation and its 
usefulness in COPD 
 
 
Contraindications to NIV- 
A. Extreme obesity 
B. Craniofacial trauma, recent facial surgery, burns 
C. Nasopharyngeal abnormalities 
D. Altered sensorium, uncooperative patients 
E. Respiratory arrest 
F. Shock  
G. High chance of aspiration 
 
Indications for Mechanical Ventilation- 
A. Contraindication or unresponsive to NIV 
B. Severe dyspnea and increased work of breathing 
C. Acute respiratory acidosis wih pH <7.25 and PaCO2> 60 mmHg 
D. Respiratory rate >35 
E. PaO2 <40mmHg 
F. Associated comorbidities like cardiac disease, metabolic abnormalities, 
sepsis, pneumonia, pulmonary embolism, pneumothorax, large pleural 
effusion 
 
 The above flowchart depicts the management of respiratory failure in acute 
exacerbation of COPD and initiation of NIV and mechanical ventilation. 
 
 
 
 
 Lung Volume Reduction Surgery:- 
 
LVRS involves reduction of lung volumes by 30% by freeing them from the 
apices. The residual lung expands and fills the thorax and hence elastic recoil is 
increased and airflow during expiration increases. 
Smoking cessation, oxygen supplementation and LVRS are the only modes of 
treatment increasing survival in COPD patients. 
 
  
ACUTE PHYSIOLOGY AGE AND CHRONIC HEALTH EVALUATION 
{APACHE} SYSTEMS I,II,III,IV 
Knaus described the APACHE score in 1981, a physiologically based classification 
system for measuring severity of illness in groups of critically ill patients. It was 
widely used for comparing outcomes, evaluate new therapies and evaluate the 
utilisation of ICU facilities. 
 
APACHE II, a simplified version was described in 1985 and was superseded by 
APACHE III in 1991 and APACHE IV in 2006, however, APACHE II has become 
the most widely used system all over the world for studying and reporting severity 
of illness.   
APACHE II score is the sum of three components:- 
1) an acute physiology score (APS) 
2) a chronic health score based on premorbid states 
3) a score based on patient‟s age 
 
 
 
 
  
The 12 variables of APACHE II are collected in the first 24 hours after admission 
and they should represent the worst physiological values.   
 
1) Age  
2) Glasgow Coma Scale 
3) Temperature 
4) Heart rate 
5) Respiratory rate 
6) Mean arterial pressure 
7) Packed cell volume 
8) WBC Count 
9) Arterial Ph 
10) Serum Sodium 
11) Serum Potassium 
12) Serum Creatinine  
13) A-a Gradient (if FiO2>0.5) or PaO2 (if FiO2 <0.5) 
14) Chronic health problems { Cirrhosis/ NYHA –IV/Severe COPD/ 
Regular HD/ Immunocompromised}  
 
TOTAL SCORE-  
 
 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS:- 
TITLE: FIRST DAY PREDICTORS OF REQUIREMENT OF MECHANICAL 
VENTILATION IN COPD PATIENTS WITH ACUTE EXACERBATION 
 AIMS AND OBJECTIVES:  To identify the first day predictors of 
requirement of mechanical ventilation in COPD patients with acute 
exacerbation 
MATERIALS AND METHODS: 
STUDY POPULATION: 
The present study was conducted on 200 patients from General Medicine wards  of  
Government Rajaji Hospital, Madurai during the period of  March 2016 to August 
2016. 
 
INCLUSION CRITERIA: 
1. All patients admitted with a primary admitting diagnosis of acute exacerbation 
of COPD.  
2. All patients must have a Prior confirmed diagnosis of COPD on the basis of 
FEV1/FVC<0.70 and should be on regular follow up and treatment 
3. Exacerbation of COPD was diagnosed on basis of worsening of atleast one of 
these symptoms- dyspnea, cough, sputum production   
 
EXCLUSION CRITERIA:  
 1. Patients with underlying COPD admitted with another primary admitting 
diagnosis (eg. Stroke, Acute Myocardial Infarction) were excluded from the study 
2. Patients with acute respiratory failure secondary to bronchiectasis, bronchial 
asthma, active/inactive tuberculosis, pneumothorax, pulmonary embolism, 
pulmonary edema were excluded from the study 
                                                  
ANTICIPATED OUTCOME: Endotracheal Intubation for Mechanical 
Ventilation 
 
 
DATA COLLECTION: A previously designed proforma was used to collect 
the demographic and clinical details of the patients.  All the patients were given 
detailed clinical evaluation, appropriate investigations. 
The demographic profile collected by questionnaire at the time of admission 
included age, sex, smoking status. Patient vitals including heart rate, blood 
pressure and respiratory rate was recorded. Premorbid functional status for the last 
month according to the modified Menzies criteria was calculated from the patient 
or relatives if the patient was unable to provide the details. Arterial blood gas 
analysis, liver function tests, renal function tests, serum electrolytes was done 
routinely for the patients. Acute Physiology and Chronic Health Evaluation II ( 
APACHE II) score was calculated for each patient from the following data (Age, 
Temperature, Mean Arterial Pressure, Heart Rate, Respiratory Rate, FiO2, Arterial 
pH, Serum HCO3, Serum sodium, Serum Potassium, Serum Creatinine, Packed 
Cell Volume, WBC count, Glasgow Coma Scale).  
Patients were promptly intubated if NIV was contraindicated or not responding to 
NIV, if they had severe dyspnea and increased work of breathing, if acute 
respiratory acidosis wih pH <7.25 and PaCO2> 60 mmHg was present, if 
respiratory rate was  >35 or if  PaO2 was <40mmHg. 
 
 
 
 
 
 
LABORATORY INVESTIGATIONS:  
Hemoglobin 
WBC count 
Blood Glucose 
Bilirubin – Total, Direct, Indirect 
SGOT, SGPT 
Total Protein 
Serum Albumin 
Blood Urea 
Serum Creatinine 
Serum Sodium  
Serum Potassium  
Serum Calcium  
Arterial Blood Gas Analysis ( arterial pH, Serum Hco3) 
 
 
 
 
 
 
SCORE CALCULATION 
1) Premorbid Functional Status ( Modified Menzies Criteria) (for the 
previous 1 month)  
I. Independent- working/Living without help 
II. Restricted- able to leave house but exercise is restricted  
III. Housebound-  rarely leaves house but able to do self care  
IV. Bed/ chair bound- not able to do self care  
  2) Acute Physiology and Chronic Health Evaluation II ( APACHE II) 
score 
1) Age  
2) Glasgow Coma Scale 
3) Temperature 
4) Heart rate 
5) Respiratory rate 
6) Mean arterial pressure 
7) Packed cell volume 
8) WBC Count 
9) Arterial Ph 
10) Serum Sodium 
11) Serum Potassium 
12) Serum Creatinine  
13) A-a Gradient (if FiO2>0.5) or PaO2 (if FiO2 <0.5) 
14) Chronic health problems { Cirrhosis/ NYHA –IV/Severe COPD/ 
Regular HD/ Immunocompromised}  
 
TOTAL SCORE-  
 
 
DESIGN OF STUDY:   Prospective study 
PERIOD OF STUDY: March 2016 To August  2016 ( 6 months) 
COLLABORATING DEPARTMENTS: 
 Department of Respiratory Medicine 
 Department Of Biochemistry   
 
 
ETHICAL CLEARANCE: Obtained 
CONSENT: Individual written and informed consent. 
ANALYSIS:STATISTICAL ANALYSIS. 
CONFLICT OF INTEREST: NIL 
FINANCIAL SUPPORT:  SELF 
PARTICIPANTS:  
200 patients admitted with a primary diagnosis of acute exacerbation of COPD in 
General Medicine wards of Government Rajaji Hospital, Madurai from March 
2016 to August 2016 were included in this study.  All patients must have a Prior 
confirmed diagnosis of COPD on the basis of FEV1/FVC<0.70. Exacerbation of 
COPD was diagnosed on basis of worsening of atleast one of these symptoms- 
dyspnea, cough, sputum production.  Patients with underlying COPD admitted 
with another primary admitting diagnosis (eg. Stroke, Acute Myocardial 
Infarction) were excluded from the study. Patients with acute respiratory failure 
secondary to bronchiectasis, bronchial asthma, active/inactive tuberculosis, 
pneumothorax, pulmonary embolism, pulmonary edema were excluded from the 
study 
 
 
 
 
 DEFINITIONS USED FOR THE STUDY: 
 
 
1. COPD 
 
 
A patient was taken to have COPD only if  he/she described the typical 
history suggestive of COPD and was previously diagnosed to have COPD on the 
basis of  pulmonary function test result FEV1/FVC<0.70.  Only those COPD 
patients who were on regular  followup and treatment were included in the study.  
Exacerbation of COPD was diagnosed on basis of worsening of atleast 
one of these symptoms- dyspnea, cough, sputum production. 
 
2. Smoking 
 
 
 
A patient was termed as smoker if he/she described a history of tobacco 
smoking within the last twenty years. Those who stopped smoking completely 
before twenty years were not included as smokers. Pack years were used to 
describe the duration and magnitude of smoking habit. 
 
 
 
 
 
3. Systemic Hypertension 
 
 
 
A patient was termed to have hypertension if he/she was already diagnosed 
and was on anti-hypertensive drugs or if the systolic BP during  hospital stay was 
found more than or equal to 140 mm Hg and/ or the diastolic BP was more than or 
equal to 90 mm Hg (JNC VII). 
 
 
4. Diabetes Mellitus 
 
 
 
A patient was termed to have diabetes mellitus if he/she was already 
diagnosed or blood investigations revealed 
 
-  Fasting plasma glucose of more than or equal to 126 mg/dl 
 
- OR 
 
-  2 hour post-prandial plasma glucose more than or equal to 200 mg/dl 
 
- OR 
 
 
- Symptoms of diabetes mellitus plus random blood sugar more than 200 
mg/dl  
 
 
 
 
 
 
 
 
 
 
STATISTICAL ANALYSIS : 
The information collected regarding all the selected cases were recorded in a 
master chart. Data analysis was done with the help of computer by using SPSS 16 
software and Sigma Stat 3.5 version (2012). 
 Using this software mean, standard deviation and „p‟ value were calculated 
through One way ANOVA, Chi square test  and  P value of < 0.05 was taken as 
significant. 
 
 
 
 
 
 
 
 
 OBSERVATIONS AND RESULTS 
AGE DISTRIBUTION IN COPD 
Age 
Number Of 
Cases 
<50 44 
51-60 69 
61-70 47 
>70 40 
Total 200 
 
Of the 200 patients included in the study, 44 belonged to the age group (< 50 
years) {22%}, whereas 156 patients {78%} were over 50 years of age. We already 
know COPD is a disease more affecting elderly persons. The findings of this study 
are similar to our earlier knowledge. 
 
  
 
 
 
 
 
 
 
 
AGE DISTRIBUTION IN COPD
<50
51-60
61-70
>70
 SEX DISTRIBUTION IN COPD 
SEX No Of Cases 
Male 153 
Female 47 
Total 200 
 
Of the total 200 COPD patients used in the study, 
 Males were 153 (76.5%) 
 Females were 47 (23.5%) 
The prevalence of COPD, as we already know, is much more in males than 
females, probably due to higher prevalence of smoking in males. Our study also 
confirms the same. 
  
 
 
 
 
 
 
 
SEX DISTRIBUTION IN COPD
Male
Female
 SMOKING IN COPD 
 
SMOKING  
STATUS 
No Of 
Cases 
Smokers 150 
Non Smokers 50 
Total 200 
 
As we already know, the major etiological factor in COPD is cigarette smoking.  
In our study, smokers comprised 150 (75%) of the total 200 cases and hence our 
finding was in line with previous studies. 
  
 
 
 
 
 
 
 
Smoking Prevalence in COPD
Smokers
Non Smokers
 DURATION OF SMOKING v/s MECHANICAL VENTILATION 
Pack years No Of Cases MV No MV 
 1 - 10    55 0 55 
 11 - 20   54 10 44 
21- 30  28 23 5 
>30 13 9 4 
Total 150 42 108 
Mean   27.85 15.33 
SD   6.99 6.81 
P Value    <0.001 
 
In our study,  
 none of the 55 cases who had smoked for 1-10 pack years eventually 
required mechanical ventilation 
 10 of the 54 cases (18.5%) with pack years11-20 needed mechanical 
ventilation 
 23 of the 28 (82.14%) with pack years 21-30 needed mechanical ventilation 
  9 of the 13 cases (69.2%) with pack years >30 needed mechanical 
ventilation 
P value was found to be <0.001 which shows that the association between duration 
of smoking and the need for mechanical ventilation is significant. Hence COPD 
patients with long duration of smoking as measured by pack years are more likely 
to require mechanical ventilation in case of acute exacerbations. 
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DURATION OF SMOKING v/s MECHANICAL 
VENTILATION
Yes No
pH VERSUS NEED FOR MECHANICAL VENTILATION:- 
Ph 
No Of 
Cases MV No MV 
<7.2 34 33 1 
>7.2 166 36 130 
Total 200 69 131 
Mean   7.13 7.35 
SD   0.144 0.05 
P'Value    <0.001 
 
Of the total 200 COPD patients, 34 had a pH of <7.2 , of whom 33 eventually 
needed mechanical ventilation (97.05%), whereas only 36 of 166 patients with pH 
>7.2 eventually needed mechanical ventilation (19.14%).  
P value of <0.001 obtained by our study clearly indicates that pH <7.2 is an 
independent predictor for mechanical ventilation in COPD patients. 
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GLASGOW COMA SCALE VERSUS NEED FOR MECHANICAL 
VENTILATION:- 
 
GCS No Of Cases Yes No 
<13 32 30 2 
>13 168 17 151 
Total 200 47 153 
Mean 
 
13.21 14.85 
SD 
 
1.19 0.43 
P Value 
 
<0.03 
 
Of  the total 200 COPD patients, 32 had a GCS < 13 , of whom 30 (93.75%) 
eventually needed mechanical ventilation (97.05%), whereas only 17 of 168 
patients with GCS >13 (10.11%) eventually needed mechanical ventilation.  
P value  of <0.03 obtained by our study clearly indicates that GCS< 13 is an 
independent predictor for need for mechanical ventilation in COPD patients. 
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GCS v/s MECHANICAL VENTILATION
Yes No
 APACHE II SCORE VERSUS NEED FOR MECHANICAL VENTILATION:- 
APACHE 
II 
No Of Cases MV No MV 
<15 137 7 130 
>15 63 40 23 
Total 200 47 153 
Mean   18.81 11.88 
SD   3.34 2.84 
P'Value    <0.001 
 
Of the total 200 patients, 137 had an APACHE II score of < 15 on the day of 
admission, of which 7 {5.1%} eventually needed mechanical ventilation, whereas 
63 patients had APACHE II score > 15 on the day of admission of whom  40 
{63.4%} needed mechanical ventilation.  
P value <0.001 obtained by our study indicates that APACHE II score >15 on the 
day of admission is an independent predictor of need for mechanical ventilation. 
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APACHE II score v/s MECHANICAL VENTILATION
Yes No
SERUM ALBUMIN VERSUS NEED FOR MECHANICAL VENTILATION:- 
SERUM 
ALBUMIN  
No Of Cases MV No MV 
<3 56 37 19 
>3 144 10 134 
Total 200 47 153 
Mean   2.37 3.44 
SD   0.65 0.54 
P Value    <0.001 
 
Of the total 20 patients included in study, 56 had a serum albumin <3 g/dl on the 
day of admission of whom 37 {66.07%} were eventually given mechanical 
ventilation whereas 144 had serum albumin > 3 g/dl on the day of admission of 
whom 10 {6.94%} eventually needed mechanical ventilation.  
P value < 0.001 indicates that serum albumin < 3 g/dl on the day of admission is an 
independent predictor of need for mechanical ventilation.  
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SERUM ALBUMIN v/s MECHANICAL 
VENTILATION
Yes No
PaCO2 VERSUS NEED FOR MECHANICAL VENTILATION:- 
PaCO2  
(mm Hg) 
No Of 
Cases MV No MV 
<60 51 1 50 
>60 149 46 103 
Total 200 47 153 
Mean   73.64 63.76 
SD   5.27 6.19 
P'Value    <0.001 
    
Of the total 200 patients, 51 had a PaCO2 of < 60mm Hg, of which1 patient 
eventually was given mechanical ventilation. 149 patients had a PaCO2 >60 
mmHg, of whom 46 later had to be given mechanical ventilation (30.8%) 
P value was <0.001 which indicates that PaCO2 > 60 mmHg on the day of 
admission is a significant independent predictor of need for mechanical ventilation.  
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PaCO2  v/s MECHANICAL VENTILATION
Yes No
PREMORBID FUNCTIONAL SCORE VERSUS NEED FOR MECHANICAL 
VENTILATION:- 
  Premorbid Functional Status 
MV I II III IV 
Yes (47) 0 14 15 18 
No (153)  119 29 5 0 
TOTAL   119 43  20  18  
     
 
I & II 14 148 
 
 
III & IV 33 5 
 
 
 p value 
0.035 
Significant 
  
 Of the total 200 patients, 119 were assigned as Grade I, with none of them needing 
mechanical ventilation, 43 were included in Grade II with 14  (32.5%) needing 
mechanical ventilation,  20 were in Grade III with 15 of them (75%)  needing 
mechanical ventilation and 18 were in Grade IV with all (100%) needing 
mechanical ventilation eventually. Hence, 14 of the 152 patients in Grade I and II 
(9.2%) and 33 of the 38 patients  (86.8%) in Grade III and IV needed mechanical 
ventilation. 
 
P value of 0.035 is significant indicating that premorbid functional status of Grade 
III and IV is an independent predictor for need of mechanical ventilation. 
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DISCUSSION:- 
In our study, majority (78%) of patients were over 50 years of age. We already 
know COPD is a disease more affecting elderly persons. The findings of this study 
are similar to our earlier knowledge. 
In our study, majority (76.5%) of patients were males. The prevalence of COPD, as 
we already know, is much more in males than females, probably due to higher 
prevalence of smoking in males. Our study also follows the same prevalence 
pattern. 
In our study, smokers comprised 150 (75%) of the total 200 cases. As we already 
know, the major etiological factor in COPD is cigarette smoking, hence our finding 
was in line with previous studies. 
Madkour et al have earlier described smoking duration in  pack years as a predictor 
of need for mechanical ventilation. In our study, P value of <0.001 shows that the 
association between duration of smoking and the need for mechanical ventilation is 
significant. Hence our findings follow the same trend as previous studies and 
COPD patients with long duration of smoking as measured by pack years are more 
likely to require mechanical ventilation in case of acute exacerbations. 
 Arterial Blood pH on the day of admission has been earlier studied by other 
groups. Khilnani et al have found pH <7.26 to be significant with respect to need 
for  mechanical ventilation. Hoo et al have also identified pH< 7.25 to be 
significant, with maximum rate of intubation with pH< 7.20.  Kumar et al have 
found pH < 7.20 to be a significant predictor. In our study, a similar trend was 
found with 97.05% of patients with pH <7.2 on the first day eventually going for 
mechanical ventilation. Ventilation-perfusion mismatch, alveolar hypoventilation 
and respiratory muscle fatigue are reasons for acidosis in severe acute 
exacerbations. 
Glasgow Coma Scale <9 has been identified by Ucgun et al as a significant 
predictor of mechanical ventilation. Our study has indicated a GCS < 13 to be 
significant. The lower threshold for our study is probably due to higher rates of 
intubation and relatively low availability of noninvasive ventilation. 
APACHE II score> 22 has been described by Vitacca et al as significant in 
predicting need for mechanical ventilation. APACHE II > 23 was found significant 
by Ucgun et al  while Kumar et al have identified an APACHE II score > 11.5 as 
independent predictor of intubation. Our study had a pattern more similar to the 
latter, with 63.4% of patients with APACHE >15 eventually needing mechanical 
ventilation. 
Serum Albumin< 3.5 g/dl  has earlier been found significant in predicting 
mechanical ventilation by Khilnani et al. Whereas in their study, Vitacca et al 
found albumin to have no significant relationship with mechanical ventilation. Our 
study has paralleled the findings of Khilnani et al and indicates serum albumin < 3 
g/dl to be significant predictor of intubation as 66.07% of patients with albumin 
<3g/dl on the first day needed mechanical ventilation. Serum Albumin is a proven 
marker of nutritional status of patients. COPD patients who are malnourished are 
more likely to go in for intubation and mechanical ventilation during an acute 
insult like an exacerbation. This explains the reason for the predictive ability of 
low serum albumin.  
 PaCO2 > 68 mm Hg has been described by Kumar et al as a significant predictor 
of mechanical ventilation. In our study, first day PaCO2 > 60 mm Hg has been 
found to be significant as 30.8% of patients with PaCO2 > 60 mm Hg needed 
mechanical ventilation during the course of their hospital stay. Ventilation-
perfusion mismatch, alveolar hypoventilation and respiratory muscle fatigue are 
reasons for increased PaCO2 in severe acute exacerbations.  
Premorbid functional status shows the severity of COPD as well as associated 
underlying comorbid conditions.  Menzies et al have shown that premorbid status 
is the most significant factor in predicting outcome. Kumar et al showed that worse 
premorbid status can predict need for mechanical ventilation. In our study, 86.8% 
of patients with worse (Grade III and Grade IV) premorbid functional status 
according to modified Menzies score eventually required mechanical ventilation. 
Hence the finding in our study parallels the previous studies. 
Hence, our study has found that duration of smoking in pack years, first day values 
of arterial blood pH, PaCO2, Glasgow Coma Scale, APACHE II score, serum 
albumin and premorbid functional status can be used to predict the need for 
mechanical ventilation in COPD patients with acute exacerbation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIMITATIONS:- 
1. Relatively low availability of Non Invasive Ventilation  during the course of 
the study may have led to a higher rate of intubation  and mechanical 
ventilation. 
2. Our centre being a tertiary care centre, COPD patients with more severity 
and thus with more need for mechanical ventilation are referred to us which 
may have influenced the results. 
 
 
 
 
 
 
 
 
 
 
SUMMARY:- 
The study “First Day Predictors Of Requirement Of Mechanical Ventilation In 
COPD Patients With Acute Exacerbation” was done to identify quantitative and 
qualitative variables which could help identify those patients who would 
eventually require mechanical ventilation, on the first day of admission itself, so as 
to help allocating scanty ICU facilities more effectively. 
200 patients were included in the study according to the inclusion and exclusion 
criteria and evaluated on history, clinical and biochemical aspects, after obtaining 
the necessary institutional ethical clearance  and informed consent from each 
patient. The data thus obtained was entered in Microsoft Excel Spreadsheet and 
subjected to statistical analysis. 
In our study, 153 cases were males and 47 were females, probably due to increased 
prevalence of smoking among males. Majority (78%) cases were over 50 years of 
age which is in line with previous observations that COPD is a disease affecting 
the elderly more. 
150 cases in our study were smokers (75%), which is coinciding with our previous 
knowledge that smoking is the major causative factor of COPD.  
On the day of admission itself variables like arterial blood pH, PaCO2, serum 
albumin, APACHE II score, Glasgow Coma Scale and duration of smoking in pack 
years was measured and these values were entered into the spreadsheet for all 
patients.  Each patient was followed up during the hospital stay and intubated if 
fulfilling the indications for mechanical ventilation. The above mentioned 
variables were compared between those cases managed without mechanical 
ventilation and those who ultimately required mechanical ventilation. 
In our study the association between duration of cigarette smoking in pack years 
and the need for mechanical ventilation was found to be significant, hence COPD 
patients with long duration of smoking are more likely to require mechanical 
ventilation during acute exacerbation. 
The association between low arterial blood pH (< 7.2) and the need for mechanical 
ventilation was found to be significant, hence COPD patients with more acidosis 
are more likely to require mechanical ventilation in an acute exacerbation. 
The association between high PaCO2 (> 60mm Hg) on the day of admission and 
the need for mechanical ventilation was found to be significant, hence COPD 
patients with higher PaCO2 are more likely to require mechanical ventilation in an 
acute exacerbation. 
Association between low GCS (<13) and the need for mechanical ventilation was 
significant, hence COPD patients with altered sensorium are likely to need 
mechanical ventilation in an acute exacerbation.  
The association between high APACHE II score (>15) and the need for mechanical 
ventilation was significant, hence COPD patients with high APACHE II score on 
the day of admission are more likely to require mechanical ventilation. 
The association between low serum albumin (<3g/dl) and the need for mechanical 
ventilation was found significant, hence COPD patients with less serum albumin 
are more likely to require mechanical ventilation in an acute exacerbation. 
Association between premorbid functional status (Grade III and IV) as measured 
by modified Menzies scale and the need for mechanical ventilation was significant, 
hence COPD patients with higher premorbid score are more likely to require 
mechanical ventilation in an acute exacerbation. 
Hence, our study has found that duration of smoking in pack years, first day values 
of arterial blood pH, PaCO2, Glasgow Coma Scale, APACHE II score, serum 
albumin and premorbid functional status can be used to predict the need for 
mechanical ventilation in COPD patients with acute exacerbation. 
 
 
 
CONCLUSION:- 
  Males comprise the majority of COPD cases, probably due to increased 
prevalence of smoking habit among males. 
  Majority of cases are over 50 years of age, hence COPD is a disease 
affecting the elderly more. 
 Majority of cases are smokers, which is in line with previous knowledge that 
smoking is the major causative factor for COPD. 
 Long duration of smoking ( as measured in pack years) is a significant 
predictor of need for mechanical ventilation in COPD patients with acute 
exacerbation. 
 Low arterial blood pH on the day of admission (<7.2) is a significant 
predictor of need for mechanical ventilation in COPD patients with acute 
exacerbation. 
 Altered sensorium on the day of admission ( as measured by a low Glasgow 
Coma Scale {<13}) is a significant predictor of need for mechanical 
ventilation in COPD patients with acute exacerbation. 
 A high APACHE II score on the day of admission (>15) is a significant 
predictor of need for mechanical ventilation in COPD patients with acute 
exacerbation. 
 Low serum albumin on the day of admission (<3.5 g/dl) is a significant 
predictor of need for mechanical ventilation in COPD patients with acute 
exacerbation. 
 High PaCO2 (>60mm Hg) on the day of admission is a significant predictor 
of need for mechanical ventilation in COPD patients with acute 
exacerbation. 
 Worse premorbid functional status ( as measured by Grade III or IV on the 
modified Menzies score)  is a significant predictor of need for mechanical 
ventilation in COPD patients with acute exacerbation. 
 Hence, using these above mentioned variables, it is possible to classify 
according to severity and identify on the day of admission itself, those 
COPD patients with acute exacerbation who may, during their hospital stay, 
require mechanical ventilation.  
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PROFORMA :- 
 
Name: 
Age / Sex: 
IP / OP no: 
Occupation: 
 
Presenting complaints: 
 
H/o increased dyspnea 
H/o increased cough 
H/o increased sputum production  
 
Past History: 
H/o CLD, DM, HT, CKD, CVD, DRUG INTAKE, THYROID DISORDER , 
EPILEPSY , HEPATITIS.  
 Personal history 
alcoholic/ non alcoholic 
smoker/ nonsmoker 
 
Clinical Examination: 
General examination 
 
 
 
 
 
 
Nutrition  
Glasgow Coma Scale 
Orientation 
Afebrile/Febrile 
Pallor/no pallor 
Cyanosis/ No cyanosis 
Clubbing/No clubbing 
Pedal edema / no pedal edema  
Vitals  Temperature  
Pulse rate 
Blood pressure 
Respiratory rate 
Oxygen saturation 
RESPIRATORY SYSTEM 
 
 
 
 
 
 
 
CARDIOVASCULAR SYSTEM 
 
 
 
 
 
 
 
 
 
 
CENTRAL NERVOUS 
SYSTEM 
 
 
 
 ABDOMEN 
 
 
 
 
 
Laboratory investigations: 
1. Hemoglobin, complete blood count,  platelet count 
2. Blood urea, serum creatinine, blood glucose 
3. Serum Sodium, Serum Potassium, Serum Calcium 
4.  Bilirubin – Total, Direct, Indirect 
5. SGOT, SGPT, Total Protein, Serum Albumin 
6. Arterial Blood Gas Analysis 
 
Score Calculation 
1. Premorbid Functional Status ( Modified Menzies Criteria) 
I- Independent- working/Living without help 
II- Restricted- able to leave house but exercise is restricted 
III- Housebound-  rarely leaves house but able to do self care 
IV- Bed/ chair bound- not able to do self care 
 2. Acute Physiology and Chronic Health Evaluation II ( APACHE II) score 
1. Age 
2. Glasgow Coma Scale 
3. Temperature 
4. Heart rate 
5. Respiratory rate 
6. Mean arterial pressure 
7. Packed cell volume 
8. WBC Count 
9. A-a Gradient (if FiO2>0.5) or PaO2 (if FiO2 <0.5) 
10. Arterial pH 
11. Serum Sodium 
12. Serum Potassium 
13. Serum Creatinine 
14. Chronic health problems { Cirrhosis/ NYHA –IV/Severe 
COPD/ Regular HD/ Immunocompromised} 
TOTAL SCORE-  
 
 
Diagnosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART- 
 NAME AGE SEX SMOKER 
(Pack 
years) 
pH  GCS  PaCO2  PREMORBID 
FUNCTIONAL 
STATUS  
SERUM 
ALBUMIN 
APACHE 
II SCORE 
MECHANICAL 
VENTILATION 
            
            
1 A1 60 M 30 7.12 15 74 IV 2.9 21 YES 
2 A2 50 M 25 7.3 15 78 IV 2.3 20 YES 
3 A3 65 M 30 7.1 13 70 II 2.8 20 YES 
4 A4 58 M 30 6.9 12 69 IV 3.2 20 YES 
5 A5 56 M 30 6.92 14 78 III 1.7 18 YES 
6 A6 52 M 25 7.1 13 80 II 2.5 17 YES 
7 A7 75 M 35 7.05 15 82 II 3.1 19 YES 
8 A8 58 M 15 6.9 14 68 IV 2.3 10 YES 
9 A9 46 M 15 7.2 14 60 III 3.2 20 YES 
10 A10 52 M 25 7.13 15 76 II 1.4 18 YES 
11 A11 54 M 20 7.15 13 69 II 2.5 25 YES 
12 A12 62 M 0 7.25 12 80 IV 2.2 16 YES 
13 A13 56 M 40 7.35 12 78 III 3.3 18 YES 
14 A14 49 M 25 7.33 13 69 IV 1.9 15 YES 
15 A15 75 M 20 7.32 12 73 IV 1.2 25 YES 
16 A16 67 M 30 7.34 12 78 IV 2.1 20 YES 
17 A17 69 M 20 7.18 12 80 IV 2.3 23 YES 
18 A18 64 M 30 7.2 12 82 IV 2.1 26 YES 
19 A19 70 M 30 7.11 14 65 IV 2.8 20 YES 
20 A20 62 M 20 7.15 12 68 II 2.5 24 YES 
21 A21 60 M 15 7.17 13 69 III 1.5 23 YES 
22 A22 59 M 20 7.21 13 70 IV 1.9 24 YES 
23 A23 66 M 25 7.11 13 75 III 2.2 22 YES 
24 A24 67 M 20 7.15 12 77 III 2.1 20 YES 
25 A25 63 M 30 7.09 15 80 III 2.4 21 YES 
26 A 58 M 25 7.13 12 71 III 2.2 16 YES 
27 B 65 M 20 7.11 13 69 II 3.5 19 YES 
28 C 52 F 0 7.12 15 70 IV 3.2 18 YES 
29 D 46 M 35 6.9 13 74 III 2.8 20 YES 
30 E 58 M 25 6.89 13 77 II 1.9 14 YES 
31 F 72 F 0 7.21 11 69 II 1.4 20 YES 
32 G 65 M 30 7.2 13 80 IV 2.5 17 YES 
33 H 62 M 40 7.34 13 77 IV 3.4 16 YES 
34 I 54 M 30 7.36 13 78 III 1.6 18 YES 
35 J 75 M 35 7.22 14 80 II 2.8 16 YES 
36 K 52 F 0 7.23 11 69 II 1.5 21 YES 
37 L 68 M 40 7.25 15 72 IV 3.4 17 YES 
38 M 80 M 40 7.13 15 78 III 2.2 15 YES 
39 N 61 M 0 6.9 15 76 II 1.9 19 YES 
40 O 56 F 25 6.92 15 72 II 1.4 16 YES 
41 P 77 M 35 6.89 14 75 IV 3.1 21 YES 
42 R 54 M 30 6.9 12 70 III 1.2 13 YES 
43 S 64 M 30 7.05 12 65 IV 2.1 19 YES 
44 T 48 M 30 7.11 12 77 III 3 18 YES 
45 U 55 M 25 6.92 14 73 III 2.1 16 YES 
46 V 78 M 30 7.34 13 64 III 2.4 15 YES 
47 W 62 M 40 7.2 13 77 II 3.3 15 YES 
48 X 81 M 30 7.21 14 80 III 1.6 20 NO 
49 Y 52 M 0 7.35 14 78 III 2.2 18 NO 
50 Z 55 F 25 6.92 14 70 II 1.4 17 NO 
51 1 67 M 10 7.39 13 56 II 3.2 17 NO 
52 2 88 M 10 7.36 12 58 II 3.6 13 NO 
53 3 52 F 0 7.34 15 64 I 3.3 11 NO 
54 4 74 M 10 7.32 15 50 I 3.6 14 NO 
55 5 58 M 10 7.36 14 57 I 2.2 11 NO 
56 6 82 M 20 7.37 15 58 II 3.3 17 NO 
57 7 61 F 0 7.34 15 62 I 3.1 9 NO 
58 8 74 M 10 7.28 14 64 I 3.5 12 NO 
59 9 78 M 10 7.39 15 66 II 3.1 13 NO 
60 10 55 F 0 7.37 15 65 II 3.5 13 NO 
61 11 69 M 10 7.29 15 71 I 2.9 12 NO 
62 12 81 M 20 7.3 15 58 II 3.1 8 NO 
63 13 45 F 0 7.36 15 62 I 3.7 12 NO 
64 14 54 M 10 7.37 15 55 I 4.1 13 NO 
65 15 78 M 10 7.34 15 50 I 3.8 15 NO 
66 16 64 M 40 7.36 14 48 I 3.3 13 NO 
67 17 58 M 0 7.35 15 60 II 4.2 8 NO 
68 18 45 F 0 7.39 14 63 I 3.8 17 NO 
69 19 67 M 35 7.34 15 64 I 3.1 11 NO 
70 20 45 F 10 7.35 15 66 II 3.2 7 NO 
71 21 59 M 20 7.37 15 68 I 3.4 13 NO 
72 22 72 M 25 7.34 15 70 I 3.5 11 NO 
73 23 80 M 0 7.37 15 74 I 3.2 9 NO 
74 24 52 F 0 7.36 15 58 I 3.1 14 NO 
75 25 66 M 15 7.36 15 68 I 2.8 17 NO 
76 26 58 M 10 7.39 15 64 II 4.6 9 NO 
77 27 42 F 0 7.34 14 60 I 3.8 7 NO 
78 28 76 M 20 7.37 15 72 I 3.8 17 NO 
79 29 61 M 20 7.35 15 68 I 3.4 13 NO 
80 30 45 M 10 7.37 15 64 II 3.8 12 NO 
81 31 74 F 0 7.34 15 68 I 4.6 8 NO 
82 32 52 M 0 7.33 15 60 I 3.5 12 NO 
83 33 86 M 20 7.35 15 68 I 3.1 17 NO 
84 34 45 M 20 7.39 15 60 II 2.8 13 NO 
85 35 77 M 10 7.37 15 58 I 3.5 13 NO 
86 36 54 M 10 7.37 15 64 I 3.2 11 NO 
87 37 48 F 0 7.36 15 62 I 3.2 8 NO 
88 38 42 M 20 7.34 14 63 I 3.8 12 NO 
89 39 62 M 10 7.34 14 70 II 3.5 13 NO 
90 40 68 M 20 7.37 15 72 II 3.3 13 NO 
91 41 52 F 0 7.38 15 56 I 3.2 17 NO 
92 42 53 M 10 7.39 15 58 I 4.1 17 NO 
93 43 44 M 15 7.38 15 59 I 3.1 8 NO 
94 44 60 M 10 7.38 15 67 I 3.1 7 NO 
95 45 47 F 0 7.34 15 64 I 4.1 13 NO 
96 46 41 M 20 7.24 15 65 I 4.5 8 NO 
97 47 55 M 10 7.39 15 55 II 3.1 12 NO 
98 48 61 F 0 7.36 15 50 I 2.7 9 NO 
99 49 74 F 0 7.37 15 48 I 4.5 13 NO 
100 50 46 M 10 7.39 15 55 I 4.1 17 NO 
101 51 57 M 20 7.34 15 54 I 4.1 17 NO 
102 52 71 M 0 7.36 15 55 I 4.5 12 NO 
103 53 45 F 10 7.37 15 59 I 3.1 8 NO 
104 54 48 M 10 7.36 15 60 I 3.2 11 NO 
105 55 51 F 0 7.37 15 66 I 3.6 13 NO 
106 56 58 M 15 7.34 15 58 I 3.6 13 NO 
107 57 41 M 10 7.37 15 70 I 3.1 11 NO 
108 58 78 M 0 7.37 15 58 I 4.5 17 NO 
109 59 52 F 10 7.34 15 55 I 3.4 14 NO 
110 60 64 M 40 7.36 15 60 I 3.1 13 NO 
111 61 63 M 10 7.33 15 62 I 3.2 11 NO 
112 62 56 F 0 7.37 15 72 I 3.7 11 NO 
113 63 49 M 20 7.39 15 60 II 3.4 17 NO 
114 64 41 M 15 7.38 15 55 I 3.3 12 NO 
115 65 59 F 0 7.37 15 59 I 3.9 11 NO 
116 66 71 M 10 7.37 15 60 III 3.5 10 NO 
117 67 68 M 20 7.36 15 65 I 3.4 12 NO 
118 68 59 M 10 7.37 15 68 II 3.6 14 NO 
119 69 59 M 20 7.34 15 70 I 3.1 13 NO 
120 70 41 F 0 7.36 15 70 I 3.9 11 NO 
121 71 54 M 15 7.37 15 74 I 3.2 17 NO 
122 72 47 F 10 7.28 15 60 I 3.4 16 NO 
123 73 52 M 20 7.29 15 56 I 3.8 10 NO 
124 74 63 M 15 7.39 14 45 I 2.1 13 NO 
125 75 49 M 0 7.39 14 60 I 3.3 9 NO 
126 76 42 F 0 7.34 15 50 I 3.1 11 NO 
127 77 56 M 15 7.33 15 55 I 2.9 12 NO 
128 78 54 M 10 7.36 15 58 I 3.2 12 NO 
129 79 78 M 30 7.37 15 73 I 2.9 17 NO 
130 80 64 M 20 7.29 15 70 I 3.3 13 NO 
131 81 58 M 20 7.37 15 68 I 2.1 13 NO 
132 82 45 F 0 7.32 15 66 II 3.9 9 NO 
133 83 67 M 15 7.37 15 62 I 3.3 14 NO 
134 84 45 F 10 7.33 15 60 II 2.3 11 NO 
135 85 59 M 20 7.36 15 70 I 3.7 12 NO 
136 86 72 M 25 7.34 15 67 I 2.4 9 NO 
137 87 80 M 0 7.36 15 63 I 3.8 7 NO 
138 88 52 F 0 7.39 14 64 I 3.3 13 NO 
139 89 66 M 35 7.37 15 66 I 3.8 17 NO 
140 90 58 M 10 7.39 15 70 I 3.3 12 NO 
141 91 42 F 0 7.37 15 68 I 3.4 14 NO 
142 92 76 M 20 7.34 15 63 II 3.6 10 NO 
143 93 61 M 10 7.34 15 60 I 3.6 7 NO 
144 94 45 M 10 7.37 15 74 I 3.5 9 NO 
145 95 74 F 0 7.36 15 68 I 3.2 13 NO 
146 96 52 M 0 7.36 15 64 I 3.4 11 NO 
147 97 86 M 10 7.34 15 63 I 3.1 11 NO 
148 98 45 M 20 7.33 15 68 II 3.7 12 NO 
149 99 77 M 10 7.3 15 72 I 3.8 9 NO 
150 100 54 M 10 7.39 15 65 I 3.2 7 NO 
151 101 77 M 10 7.37 14 66 I 2.9 17 NO 
152 102 51 F 0 7.39 15 60 I 3.9 13 NO 
153 103 58 M 10 7.39 15 64 I 4.2 10 NO 
154 104 41 M 10 7.34 15 66 I 4.2 9 NO 
155 105 78 M 0 7.39 15 63 II 3.8 10 NO 
156 106 52 F 10 7.35 15 68 I 3.9 10 NO 
157 107 44 M 10 7.37 15 70 II 3.7 7 NO 
158 108 63 M 10 7.36 15 68 I 3.2 9 NO 
159 109 56 F 0 7.39 15 68 I 3.7 10 NO 
160 110 49 M 20 7.34 15 71 I 3.9 11 NO 
161 111 41 M 16 7.3 15 70 I 3.4 13 NO 
162 112 59 F 0 7.35 15 66 I 3.8 10 NO 
163 113 71 M 10 7.36 15 62 I 3.4 11 NO 
164 114 68 M 10 7.34 15 70 II 3.9 9 NO 
165 115 64 M 20 7.37 14 66 I 4.1 10 NO 
166 116 59 M 20 7.34 15 61 I 3.2 10 NO 
167 117 41 F 0 7.37 15 64 I 3.7 13 NO 
168 118 54 M 15 7.39 15 60 I 3.3 11 NO 
169 119 47 F 10 7.3 15 70 I 3.4 9 NO 
170 120 52 M 20 7.36 15 75 I 3.7 10 NO 
171 121 63 M 15 7.37 15 64 I 4.2 13 NO 
172 122 49 M 0 7.32 15 62 I 3.6 10 NO 
173 123 42 M 20 7.39 15 65 I 4.3 11 NO 
174 124 62 M 10 7.35 15 63 III 3.9 11 NO 
175 125 68 M 20 7.32 15 68 II 3.5 17 NO 
176 126 52 F 0 7.28 15 68 I 3.3 9 NO 
177 127 53 M 10 7.3 15 62 II 3.5 10 NO 
178 128 64 M 20 7.36 14 65 I 3.2 12 NO 
179 129 60 M 10 7.37 15 70 I 3.2 10 NO 
180 130 47 F 0 7.36 15 60 I 4.1 9 NO 
181 131 41 M 20 7.32 15 67 I 3.8 12 NO 
182 132 55 M 10 7.39 15 60 I 3.8 10 NO 
183 133 61 F 0 7.37 15 70 I 3.3 10 NO 
184 134 74 F 0 7.37 15 75 I 3.2 9 NO 
185 135 46 M 10 7.36 15 70 I 3.7 11 NO 
186 136 57 M 10 7.38 15 65 I 3.3 12 NO 
187 137 71 M 0 7.34 15 61 I 3.2 9 NO 
188 138 45 F 10 7.38 15 65 I 3.1 13 NO 
189 139 48 M 10 7.33 15 60 II 3.3 11 NO 
190 140 55 F 10 7.38 14 62 I 2.8 9 NO 
191 141 67 M 20 7.36 15 60 I 3.4 10 NO 
192 142 88 M 10 7.32 15 62 I 3.9 14 NO 
193 143 52 F 0 7.39 15 68 II 4.4 13 NO 
194 144 74 M 20 7.34 14 70 I 2.5 9 NO 
195 145 58 M 10 7.39 15 74 III 3.4 10 NO 
196 146 82 M 20 7.32 15 62 I 2.6 16 NO 
197 147 61 F 0 7.36 15 60 I 2.9 17 NO 
190 148 66 M 15 7.28 15 63 I 3.8 10 NO 
199 149 55 F 0 7.36 15 65 I 3.9 13 NO 
200 150 69 M 20 7.3 15 70 II 3.8 11 NO 
 
 
 
  
 
 
 
 
  
  
 
